Table 2.
Adverse events after the EsophyX-TIF procedure categorized by the MedDRA classification system and grouped by their duration
| Adverse event | ≤1 Week | 1 Week to 1 month | >1 Month |
|---|---|---|---|
| Musculoskeletal pain | 8 (9%) | 8 (9%) | |
| Abdominal pain upper | 8 (9%) | 4 (5%) | 1 (1%) |
| Pharyngolaryngeal pain | 6 (7%) | 1 (1%) | |
| Nausea | 6 (7%) | 1 (1%) | |
| Epigastric pain | 4 (5%) | 2 (2%) | |
| Application site bleeding | 5 (6%) | ||
| Pyrexia | 3 (4%) | ||
| Dysphagia | 3 (4%) | ||
| Diarrhea | 2 (2%) | ||
| Vomiting | 2 (2%) |
Values represent number of patients experiencing an adverse event for each of the time periods